Petra Grbčić
University of Rijeka
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Petra Grbčić.
Journal of Enzyme Inhibition and Medicinal Chemistry | 2018
Andrea Bistrović; Petra Grbčić; Anja Harej; Mirela Sedić; Sandra Kraljević-Pavelić; Sanja Koštrun; Janez Plavec; Damjan Makuc; Silvana Raić-Malić
Abstract Novel halogenated purines and pseudopurines with diverse aryl-substituted 1,2,3-triazoles were prepared. While p-(trifluoromethyl)-substituted 1,2,3-triazole in N-9 alkylated purine and 3-deazapurine was critical for strong albeit unselective activity on pancreatic adenocarcinoma cells CFPAC-1,1-(p-fluorophenyl)-1,2,3-triazole derivative of 7-deazapurine showed selective cytostatic effect on metastatic colon cancer cells SW620. Importantly, 1-(p-chlorophenyl)-1,2,3-triazole-tagged benzimidazole displayed the most pronounced and highly selective inhibitory effect in nM range on non-small cell lung cancer A549. This compound revealed to target molecular processes at the extracellular side and inside the plasma membrane regulated by GPLD1 and growth factor receptors PDGFR and IGF-1R leading to the inhibition of cell proliferation and induction of apoptosis mediated by p38 MAP kinase and NF-κB, respectively. Further optimisation of this compound as to reduce its toxicity in normal cells may lead to the development of novel agent effective against lung cancer. Graphical Abstract
ChemMedChem | 2018
Mateo Jelovica; Petra Grbčić; Martina Mušković; Mirela Sedić; Sandra Kraljević Pavelić; Martin Lončarić; Nela Malatesti
A series of N‐methylated and N‐oxidised tripyridyl porphyrins were synthesised, characterised, and their PDT activity was studied with six cell lines. All the tested porphyrins with a long alkyl chain, except one, were more efficient for PDT than an N‐methylated hydrophilic porphyrin and N‐oxidised porphyrin without the long alkyl chain. Generally, N‐methylated tripyridyl porphyrins were more active than those N‐oxidised, but IC50 values for phototoxicity of two N‐oxides, named TOPyP3‐C17H33O and TOPyP3‐C17H35, were still in the nanomolar concentration range for most of the tested cell lines. However, TOPyP3‐C17H35 did not show phototoxicity on human foreskin fibroblast cells. Two methylated amphiphilic porphyrins, named TMPyP3‐C17H33 and TMPyP4‐C17H35, showed significant dark toxicity, whereas none of the oxidopyridyl porphyrins were toxic without light activation. The selected photosensitisers were shown to be apoptosis inducers, and had inhibitory effects on the clonogenic growth of HCT116 and HeLa cells. All three N‐methylated amphiphilic porphyrins significantly reduced the migratory potential of HCT116 cells. Porphyrins TMPyP3‐C17H35 and TOPyP3‐C17H35 reduced the activity of acid ceramidase, whereas TOPyP3‐C17H33O had a significant inhibitory effect on sphingosine kinase 1 activity in HeLa cells. Compounds with this dual activity were shown to be the most promising photosensitisers, with potential to treat invasive cancers.
International Journal of Molecular Sciences | 2017
Andrea Bistrović; Anja Harej; Petra Grbčić; Mirela Sedić; Sandra Kraljević Pavelić; Mario Cetina; Silvana Raić-Malić
A series of mono-pyrrolo[2,3-d]pyrimidines 4a–4k, unsymmetrical bis-purine isosteres 5a–5e and symmetrical bis-pyrrolo[2,3-d]pyrimidines 6a and 6b connected via di(1,2,3-triazolyl)phenyl linker were synthesized by click chemistry. Whereas mono- 4g and bis-pseudopurine 5e showed selective inhibitory activities on cervical carcinoma (HeLa) cells, bis-pyrrolo[2,3-d]pyrimidine 6b exhibited potent and selective anti-proliferative effect in the nanomolar range on pancreatic carcinoma (CFPAC-1) cells. Among these, compound 6b induced a significant reduction in the expression level of CDK9 (cyclin-dependent kinase 9)/cyclin T1 in CFPAC-1 cells concomitant with attenuation of proliferative signaling mediated by c-Raf (rapidly accelerated fibrosarcoma) and p38 MAP (mitogen-activated protein) kinases. Our findings encourage further development of novel structurally related analog of 6b to obtain more selective anticancer agent for treating pancreatic cancer.
European Journal of Medicinal Chemistry | 2017
Tomislav Gregorić; Mirela Sedić; Petra Grbčić; Andrea Tomljenović Paravić; Sandra Kraljević Pavelić; Mario Cetina; Robert Vianello; Silvana Raić-Malić
European Journal of Medicinal Chemistry | 2018
Andrea Bistrović; Luka Krstulović; Anja Harej; Petra Grbčić; Mirela Sedić; Sanja Koštrun; Sandra Kraljević Pavelić; Miroslav Bajić; Silvana Raić-Malić
Biochemical and Biophysical Research Communications | 2017
Petra Grbčić; Ivana Tomljanović; Marko Klobučar; Sandra Kraljević Pavelić; Ksenija Lučin; Mirela Sedić
Molecular Diversity | 2018
Livio Racane; Lucija Ptiček; Mirela Sedić; Petra Grbčić; Sandra Kraljević Pavelić; Branimir Bertoša; Irena Sović; Grace Karminski-Zamola
Biochemical and Biophysical Research Communications | 2018
Marko Klobučar; Petra Grbčić; Sandra Kraljević Pavelić; Nives Jonjić; Sarah Visentin; Mirela Sedić
The 10th Joint Meeting on Medicinal Chemistry 2017 - Book of abstracts | 2017
Livio Racane; Lucija Ptiček; Mirela Sedić; Petra Grbčić; Sandra Kraljević Pavelić; Irena Sović; Grace Karminski-Zamola
Book of abstrcts | 2017
Andrea Bistrović; Luka Krstulović; Petra Grbčić; Anja Harej; Mirela Sedić; Sandra Kraljević Pavelić; Miroslav Bajić; Silvana Raić-Malić